Severe human metapneumovirus: Care challenges in the intensive care units

Human metapneumovirus (hMPV) is a significant cause of respiratory tract infections across various populations, including children, adults, the elderly, and immunocompromised individuals [1]. Primary infection with hMPV commonly occurs by the age of five, with reinfection potentially persisting throughout an individual’s lifetime. The most frequent clinical manifestations of hMPV include upper and/or lower respiratory tract infections, with lower respiratory tract infections being more prevalent [2]. These infections can lead to severe complications such as pneumonia, bronchiolitis, and acute exacerbations of asthma [3].